TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012
TCL Archive In Appropriations Hearings, Groups Seek NCI Bypass Budget, Differ On CDC Funding. April 7, 2000